Loading...
Loading...
India's lansoprazole imports from UNITED STATES total $178.0K across 44 shipments from 15 foreign suppliers. ESPEE BIOPHARMA & FINECHEM LLC leads with $37.0K in import value; the top 5 suppliers together control 72.1% of this origin. Leading Indian buyers include GRANULES INDIA LIMITED. This corridor reflects India's pharmaceutical import demand for lansoprazole — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ESPEE BIOPHARMA & FINECHEM LLC is the leading Lansoprazole supplier from UNITED STATES to India, with import value of $37.0K across 9 shipments. The top 5 suppliers — ESPEE BIOPHARMA & FINECHEM LLC, GRANULES PHARMACEUTICALS INC, ESPEE BIOPHARMA & FINECHEM LLC., SAVI CLINICALS FZ LLC, RAFF AND HALL PHARMACY — collectively account for 72.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA & FINECHEM LLC | $37.0K | 9 | 20.8% |
| 2 | GRANULES PHARMACEUTICALS INC | $33.2K | 2 | 18.6% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC. | $25.3K | 3 | 14.2% |
| 4 | SAVI CLINICALS FZ LLC | $17.3K | 2 | 9.7% |
| 5 | RAFF AND HALL PHARMACY | $15.5K | 1 | 8.7% |
| 6 | AGRACE PHARMA. | $13.4K | 1 | 7.5% |
| 7 | AMSTERDAM PHARMA (APTEKA RX INC.) | $9.2K | 1 | 5.2% |
| 8 | PREMIUM HEALTH SERVICES,INC. | $5.4K | 2 | 3.0% |
| 9 | New Life Medicals (USA), Inc. | $4.3K | 1 | 2.4% |
| 10 | ESPEE BIOPHARMA FINECHEM LLC | $3.1K | 1 | 1.7% |
| 11 | Pharmaceutical Buyers, Inc | $2.4K | 2 | 1.4% |
| 12 | NEW LIFE MEDICALS (USA), INC. | $2.2K | 1 | 1.2% |
| 13 | SPRING BIO SOLUTION LTD | $1.7K | 1 | 1.0% |
| 14 | GOOD HEALTH PHARMA SUPPLIES | $1.5K | 1 | 0.8% |
| 15 | LEGACY PHARMA SOLUTIONS | $1.4K | 2 | 0.8% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GRANULES INDIA LIMITED | $33.2K | 2 | 18.6% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED | $30.9K | 4 | 17.4% |
| 3 | ALKEM LABORATORIES LIMITED | $23.1K | 3 | 13.0% |
| 4 | MSN LABORATORIES PRIVATE LIMITED | $17.3K | 2 | 9.7% |
| 5 | AJANTA PHARMA LIMITED | $16.2K | 2 | 9.1% |
| 6 | DR.REDDY'S LABORATORIES LTD | $15.5K | 4 | 8.7% |
| 7 | COHANCE LIFESCIENCES LIMITED | $10.7K | 2 | 6.0% |
| 8 | MYLAN LABORATORIES LIMITED | $7.8K | 4 | 4.4% |
| 9 | METROCHEM API PRIVATE LIMITED | $5.4K | 4 | 3.0% |
| 10 | INVENTIA HEALTHCARE LIMITED | $5.2K | 1 | 2.9% |
| 11 | HETERO LABS LIMITED | $4.3K | 1 | 2.4% |
| 12 | AUROBINDO PHARMA LTD | $2.3K | 2 | 1.3% |
| 13 | AUROBINDO PHARMA LIMITED | $1.7K | 1 | 1.0% |
| 14 | VASUDHA PHARMA CHEM LIMITED | $1.7K | 2 | 1.0% |
| 15 | HETERO LABS LIMITED | $969 | 1 | 0.5% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Lansoprazole suppliers from UNITED STATES to India include ESPEE BIOPHARMA & FINECHEM LLC, GRANULES PHARMACEUTICALS INC, ESPEE BIOPHARMA & FINECHEM LLC.. The leading supplier is ESPEE BIOPHARMA & FINECHEM LLC with import value of $37.0K USD across 9 shipments. India imported Lansoprazole worth $178.0K USD from UNITED STATES in total across 44 shipments.
India imported Lansoprazole worth $178.0K USD from UNITED STATES across 44 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Lansoprazole sourced from UNITED STATES include GRANULES INDIA LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, ALKEM LABORATORIES LIMITED. The largest buyer is GRANULES INDIA LIMITED with $33.2K in imports across 2 shipments.
The total value of Lansoprazole imports from UNITED STATES to India is $178.0K USD, across 44 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
44 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists